Projects Search Results

aids2031 is a international consortium of partners examining the future of the HIV/AIDS epidemic. The Costs and Financing Working Group is focused on modeling and analyzing the long-term costs and financing of the epidemic, and examining scenarios in which major policy shifts now can improve the future expenditure and financing situation.

R4D is identifying innovative approaches to financing global health R&D that reduce barriers and risk in the development of new health technologies. New and improved products are needed to reduce the burden of disease, but creating these products requires difficult long-term scientific efforts, with uncertain return on investment.

Despite the success of many global health programs, there is a continuing gap between policy analysis and action.  This series, cosponsored by Results for Development and the Global Health Council, presents examples and opportunities of how evidence-based research can be translated into concrete actions that will improve the health of the poor in developing countries.

ShareThis